Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

Vaccine

Volumn 11, Issue 12, 1993, Pages 1185-1187

  Vanlandschoot, Peter ^a   Maertens, Geert ^a   Min Jou, Willy ^a   Fiers, Walter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

haemagglutinin; Influenza virus; protection; recombinant; Ribi adjuvant; vaccine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIPID A; MURAMYL DIPEPTIDE; RECOMBINANT VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INFLUENZA; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; DNA, VIRAL; HEMAGGLUTININS, VIRAL; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA VACCINE; MICE; MICE, INBRED BALB C; SUPPORT, NON-U.S. GOV'T; VACCINES, SYNTHETIC;

EID: 0027485140     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(93)90040-5     Document Type: Article

References (19)

1. Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75
2. Variation of influenza A, B, and C viruses
3. Molecular mechanisms of variation in influenza viruses
4. Molecular variation of influenza surface antigens
5. Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: Animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin
6. Host antigens associated with haemagglutinin
7. High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors
8. Membrane fusion activity of the influenza virus hemagglutinin
9. Crystalline antigen from the influenza virus envelope
10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
11. Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects
12. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
13. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or-amino acids
14. Effect of N-acetyl-muramyl-l-alanyl-d-isoglutamine on interferon production in mice by Newcastle Disease Virus
15. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus
16. Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition
17. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus
18. Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses
19. Carbohydrates of influenza virus